logo
Plus   Neg
Share
Email

Pfizer: CHMP Adopts Positive Opinion On VYNDAQEL - Quick Facts

Pfizer Inc. (PFE) announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending the approval of VYNDAQEL for the treatment of wild-type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy. The final decision from the European Union is
expected in the coming months.

Cardiomyopathy is a rare life-threatening disease characterized by the buildup of
abnormal deposits of misfolded protein called amyloid in the heart and is defined by restrictive cardiomyopathy and progressive heart failure.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from... CVS Health Corp. launched 13 new HealthHUB locations in CVS Pharmacy stores across Philadelphia and South New Jersey. The healthcare company said it developed the HealthHUB store format to help people manage chronic conditions more conveniently and affordably. The store also features health and wellness products, clinical services and expertise.
Follow RTT
>